Losartan attenuates endothelial hyperpermeability responses to VPF and high glucose but not angiotensin II.
Idris
I
I
Tyreman
N
N
Gray
S
S
Donnelly
R
R
D000804:Angiotensin II / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000494:pharmacology; D002478:Cells, Cultured; D016228:Endothelial Growth Factors / Q000502:physiology*; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology*; D005947:Glucose / Q000494:pharmacology*; D006801:Humans; D019808:Losartan / Q000494:pharmacology*; D008222:Lymphokines / Q000502:physiology*; D011651:Pulmonary Artery; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D000959:Antihypertensive Agents; D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D000804:Angiotensin II; D005947:Glucose; D019808:Losartan